High‐ and low‐affinity receptors for murine interleukin 6. distinct distribution on b and t cells

No abstract is available for this paper.

• Publication year

  1989

• Venue

  European Journal of Immunology

• Publication date

  1989-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/eji.1830191121PMID 2574680
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of a recombinant murine interleukin-6: assignment of disulfide bonds.

  1988cited by this paper
• T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor

  1988cited by this paper
• B cell growth and differentiation activity of interleukin‐hp1 and related murine plasmacytoma growth factors. synergy with interleukin 1

  1988cited by this paper
• Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor.

  1988cited by this paper
• cDNA cloning of murine interleukin‐HP1: homology with human interleukin 6

  1988cited by this paper
• Synergistic activation of human t cells by interleukin 1 and interleukin 6

  1988cited by this paper
• Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor

  1987cited by this paper
• Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression

  1987cited by this paper
• Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas

  1987cited by this paper
• Binding, internalization, and intracellular processing of protein ligands. Derivation of rate constants by computer modeling.

  1987cited by this paper
• Expression of interleukin 1 receptors is restricted to the L3T4+ subset of mature T lymphocytes.

  1987cited by this paper
• High‐affinity binding sites for human 26‐kDa protein (interleukin 6, B cell stimulatory factor‐2, human hybridoma plasmacytoma growth factor, interferon‐β2), different from those of type I interferon (α,β), on lymphoblastoid cells

  1987cited by this paper
• Characterization of a novel murine T cell-activating factor.

  1987cited by this paper
• The two-chain structure of high-affinity IL-2 receptors.

  1987cited by this paper
• Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.

  1986cited by this paper
• Recombinant human interleukin 1 alpha: purification and biological characterization.

  1986cited by this paper
• A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro.

  1986cited by this paper
• Recombinant murine GM‐CSF from E. coli has biological activity and is neutralized by a specific antiserum.

  1985cited by this paper
• Selection of highly transfectable variant from mouse mastocytoma P815

  1985cited by this paper
• Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression.

  1985cited by this paper
• Interleukin-3 supports growth of mouse pre-B-cell clones in vitro

  1984cited by this paper
• Expression of H-2Dd and H-2Ld mouse major histocompatibility antigen genes in L cells after DNA-mediated gene transfer.

  1983cited by this paper
• Molecular cloning of human interleukin 2 cDNA and its expression in E. coli

  1983cited by this paper
• Measurement of specific radioactivities in labelled hormones by self-displacement analysis.

  1983cited by this paper
• Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis

  1983cited by this paper
• A steady state model for analyzing the cellular binding, internalization and degradation of polypeptide ligands.

  1981cited by this paper
• Methods for the purification, assay, characterization and target cell binding of a colony stimulating factor (CSF-1).

  1981cited by this paper
• Enhancing the efficiency of DNA-mediated gene transfer in mammalian cells

  1981cited by this paper
• Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice

  1980cited by this paper
• Growth of factor-dependent hemopoietic precursor cell lines

  1980cited by this paper
• Ligand: a versatile computerized approach for characterization of ligand-binding systems.

  1980cited by this paper
• A simple, versatile, sensitive and volume-independent method for quantitative protein determination which is independent of other external influences.

  1979cited by this paper
• Spontaneous murine B-cell leukaemia

  1978cited by this paper
• Quantitative aspects of hormone-receptor interactions of high affinity. Effect of receptor concentration and measurement of dissociation constants of labeled and unlabeled hormones.

  1975cited by this paper
• The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

  1973cited by this paper
• Recent advances in leukemia and lymphoma

  year unknowncited by this paper

• TRAF3 is critical for initial T follicular helper cell specification via coordination of the IL-6R/IL-2R-BCL6 signaling nexus.

  2025cites this paper
• A Pathophysiologically Hypertrophic 3T3-L1 Cell Model—An Alternative to Primary Cells Isolated from DIO Mice

  2025cites this paper
• Natural Macrophage Membrane-Coated Nanoparticles as a Multifaceted Sepsis Therapeutic to Sequester Inflammatory and Toxic Mediators.

  2025cites this paper
• A Precision Gene Engineered B Cell Medicine Producing Sustained Levels of Active Factor IX for Hemophilia B Therapy

  2025cites this paper
• No evidence for paradoxical effects of tocilizumab in rodents

  2025cites this paper
• B cell development and antibody responses in human immune system mice: current status and future perspective

  2024cites this paper
• Crosstalk between microbiome, regulatory T cells and HCA2 orchestrates the inflammatory response in a murine psoriasis model

  2023cites this paper
• Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivo

  2022cites this paper
• Sympathetic nerve-adipocyte interactions in response to acute stress

  2021cites this paper
• Blocking only the bad side of IL-6 in inflammation and cancer.

  2021cites this paper
• Models of pancreatic ductal adenocarcinoma

  2021cites this paper
• Tocilizumab does not block interleukin-6 (IL-6) signaling in murine cells

  2020cites this paper
• In Vitro Th17-Polarized Human CD4+ T Cells Exacerbate Xenogeneic Graft-versus-Host Disease.

  2019cites this paper
• Biology of Blood and Marrow Transplantation

  2019cites this paper
• A mathematical model for IL-6-mediated, stem cell driven tumor growth and targeted treatment

  2018cites this paper
• Mathematical Model for IL-6-Mediated Tumor Growth, and Targeted Treatment

  2017influential citation
• Prostate-specific IL-6 transgene autonomously induce prostate neoplasm through amplifying inflammation in the prostate and peri-prostatic adipose tissue

  2017cites this paper
• Addition of interleukin-6 to mouse embryo culture increases blastocyst cell number and influences the inner cell mass to trophectoderm ratio

  2017cites this paper
• Interleukin-6 Cleavage by Meprin Metalloproteinases A and B 1 Meprin Metalloproteases Inactivate Interleukin-6 *

  2014cites this paper
• interleukin-6 Meprin metalloproteases inactivate

  2014cites this paper
• Meprin Metalloproteases Inactivate Interleukin 6*

  2014cites this paper
• marrow and peripheral blood cells of humans and rhesus monkeys Flow cytometric detection of receptors for interleukin-6 on bone

  2011cites this paper
• Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation

  2010cites this paper
• Regulation of cytokines and chemokines during the progression of acute inflammation in the human whole blood model

  2009cites this paper
• IL6 and the human limbal stem cell niche: a mediator of epithelial-stromal interaction.

  2009cites this paper
• Interleukin-6 promotes human epidermal keratinocyte proliferation and keratin cytoskeleton reorganization in culture

  2006cites this paper
• Multivalent avimer proteins evolved by exon shuffling of a family of human receptor domains

  2005cites this paper
• Multivalent avimer proteins evolved by exon shuffling of a family of human receptor domains

  2005cites this paper
• Development of an IL-6 antagonist peptide that induces apoptosis in 7TD1 cells.

  2003cites this paper
• Rat Immune System

  2003cites this paper
• Cells Respond to and Bind Countin, a Component of a Multisubunit Cell Number Counting Factor*

  2002cites this paper
• Recombinant Human Interleukin-6 Enhances the Immunoglobulin Secretion of a Rabbit–Rabbit Hybridoma

  2001cites this paper
• Activation-Induced Inhibition of Interleukin 6–Mediated T Cell Survival and Signal Transducer and Activator of Transcription 1 Signaling

  2000cites this paper
• Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action.

  1999cites this paper
• Blocking interleukin-6 activity with chimeric anti-IL6 monoclonal antibodies in multiple myeloma: effects on soluble IL6 receptor and soluble gp130.

  1998cites this paper
• The Immunoglobulin-like Module of gp130 Is Required for Signaling by Interleukin-6, but Not by Leukemia Inhibitory Factor*

  1998cites this paper
• Regulation of cytokine expression by an autoreactive B cell clone derived from MRL/MP‐lpr/lpr mice

  1998cites this paper
• Regulated expression of gp130 and IL-6 receptor alpha chain in T cell maturation and activation.

  1998cites this paper
• Interleukin‐6: Structure‐function relationships

  1997cites this paper
• Interleukin (IL)-6 Directs the Differentiation of IL-4–producing CD4+ T Cells

  1997cites this paper
• Characterization of a novel malignant B cell line with t(14;18) and t(4;11) established from a patient with acute monoblastic leukemia.

  1997cites this paper
• Roles of histidine 31 and tryptophan 34 in the structure, self-association, and folding of murine interleukin-6.

  1997cites this paper
• Anti-CD3-Activated Killer T Cells: Interleukin-6 Modulates the Induction of Major Histocompatibility Complex-Unrestricted Cytotoxicity and the Expression of Genes Coding for Cytotoxic Effector Molecules

  1997cites this paper
• Coexpression of Kit and the Receptors for Erythropoietin, Interleukin 6 and GM‐CSF on Hemopoietic Cells

  1997cites this paper
• Participation of two Ser-Ser-Phe-Tyr repeats in interleukin-6 (IL-6)-binding sites of the human IL-6 receptor.

  1996cites this paper
• Differential expression of receptors for hemopoietic growth factors on subsets of CD34+ hemopoietic cells.

  1996cites this paper
• Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model

  1996cites this paper
• Interleukin 6 receptors on human outer root sheath cells and interfollicular epidermal keratinocytesin vitro: Density-induced down regulation (DIDR) of receptors

  1996cites this paper
• Recombinant human interleukin-6: safety issues of a pleiotropic growth factor.

  1995cites this paper
• Bindung radioaktiv markierter monoklonaler Antikörper an lnterleukin-2 und -6 Rezeptoren und deren Bedeutung für die Diagnostik der Transplantatrejektion Biodistribution of radiolabeled anti-Interleukin-2 and anti-Interleukin-6 receptor monoclonal antibodies in a vascular and non-vascular transplant

  1995cites this paper
• Bindung radioaktiv markierter monoklonaler Antikörper an Interleukin-2 und -6 Rezeptoren und deren Bedeutung für die Diagnostik der Transplantatrejektion

  1995cites this paper
• Use of a biosensor with surface plasmon resonance detection for the determination of binding constants: measurement of interleukin-6 binding to the soluble interleukin-6 receptor.

  1995cites this paper
• Inhibition of ex vivo proinflammatory cytokine secretion in fatal Mycobacterium tuberculosis infection

  1995cites this paper
• Development of a human interleukin-6 receptor antagonist.

  1994cites this paper
• Reconstitution in Vitro of the Interleukin-6/Interleukin-6 Receptor Interaction: Direct Monitoring Using a Biosensor Employing Surface Plasmon Resonance Detection

  1994cites this paper
• A fast and sensitive colorimetric assay for IL-6 in hepatoma cells based on the production of a secreted form of alkaline phosphatase (SEAP).

  1994cites this paper
• Expression of interleukin 6 receptors and interleukin 6 mRNA by bovine leukaemia virus-induced tumour cells.

  1994cites this paper
• Structure‐Function analysis of human IL‐6: Identification of two distinct regions that are important for receptor binding

  1994cites this paper
• Stimulation of the B9 hybridoma cell line by soluble interleukin-6 receptors.

  1994cites this paper
• Distribution of IL-6 receptors on murine hemopoietic and lymphoid cells and the anomalous action of IL-6 in stimulating granulocytic proliferation.

  1994cites this paper
• Cytokines, phagocytosis, and Mycobacterium tuberculosis.

  1993cites this paper
• Specific covalent modification of the tryptophan residues in murine interleukin-6. Effect on biological activity and conformational stability.

  1993cites this paper
• Characterization of interleukin-10 receptors on human and mouse cells.

  1993cites this paper
• Structure-function analysis of interleukin-6 utilizing human/murine chimeric molecules. Involvement of two separate domains in receptor binding.

  1993cites this paper
• Mycobacterial 65‐kD heat shock protein induces release of proinflammatory cytokines from human monocytic cells

  1993cites this paper
• Interleukin-6 in biology and medicine.

  1993cites this paper
• Role of the C‐terminus in the activity, conformation, and stability of interleukin‐6

  1993cites this paper
• Increased IL-6 production and IL-6-mediated Ig secretion in murine host-vs-graft disease.

  1993cites this paper
• Cytokines and inflammation in cartilage degradation.

  1993cites this paper
• Flow cytometric detection of receptors for interleukin-6 on bone marrow and peripheral blood cells of humans and rhesus monkeys.

  1993cites this paper
• Differential cytokine gene expression and secretion after phagocytosis by a human monocytic cell line of Toxoplasma gondii compared with Mycobacterium tuberculosis

  1993cites this paper
• Down-regulation of interleukin 6 receptors of mouse myelomonocytic leukemic cells by leukemia inhibitory factor.

  1992cites this paper
• High and low affinity receptors for human interleukin for DA cells/leukemia inhibitory factor on human cells. Molecular characterization and cellular distribution.

  1992cites this paper
• Cytokine receptors: a new superfamily of receptors.

  1992cites this paper
• Purification and characterization of a recombinant murine interleukin-6. Isolation of N- and C-terminally truncated forms.

  1992cites this paper
• Abnormal distribution of IL-6 receptor in aged MRL/lpr mice: elevated expression on B cells and absence on CD4+ cells.

  1992cites this paper
• Kinetic analyses of the binding of leukemia inhibitory factor to receptor on cells and membranes and in detergent solution.

  1992cites this paper
• Analysis of the heterogeneity of the biological responses to native and mutant human interleukin‐6

  1992cites this paper
• Inhibition of specific pathways of myeloid cell differentiation by an activated Hox-2.4 homeobox gene.

  1992cites this paper
• Analysis of human/mouse interleukin‐6 hybrid proteins: both amino and carboxy termini of human interleukin‐6 are required for in vitro receptor binding

  1992cites this paper
• Are cytokines involved in osteoarthritic pathophysiology?

  1991cites this paper
• (Recombinant DNA; oligodeoxyribonucleotide-directed mutagenesis; N-glycosylation; cytokine; conformation-specific immunoprecipitation; mutated proteins)

  1991cites this paper
• Internal deletions in human interleukin-6: structure-function analysis.

  1991cites this paper
• Role of disulfide bonds in biologic activity of human interleukin-6.

  1991cites this paper
• The major colonic cell mitogen extractable from colonic mucosa is an N terminally extended form of basic fibroblast growth factor.

  1991cites this paper
• IL-6 and IL-1 enhance the accessory activity of human blood monocytes during differentiation to macrophages.

  1991cites this paper
• Lymphokine requirements for the development of specific cytotoxic T cells from single precursors

  1991cites this paper
• Structural and functional studies on the human interleukin-6 receptor. Binding, cross-linking, internalization, and degradation of interleukin-6 by fibroblasts transfected with human interleukin-6-receptor cDNA.

  1991cites this paper
• Comparison of the effect of IL-2 and IL-6 on the lytic activity of purified human peripheral blood large granular lymphocytes.

  1991cites this paper
• Analysis of interleukin 6 (IL-6)/IL-6 receptor system using monoclonal anti-IL-6 antibodies.

  1991cites this paper
• Effects of site-specific mutations on biologic activities of recombinant human IL-6.

  1991cites this paper
• Analysis of interleukin 6 (IL-6)/IL-6 receptor system using monoclonal anti-IL-6 antibodies.

  1991cites this paper
• Structure-function analysis of human IL-6. Epitope mapping of neutralizing monoclonal antibodies with amino- and carboxyl-terminal deletion mutants.

  1990cites this paper
• A monoclonal antibody specific for the murine IL-6-receptor inhibits the growth of a mouse plasmacytoma in vivo.

  1990cites this paper
• Interleukin 6 is essential for antibody secretion by human in vivo antigen-induced lymphoblastoid B cells.

  1990cites this paper
• The three carboxy‐terminal amino acids of human interleukin‐6 are essential for its biological activity

  1990cites this paper
• IL-6 Receptor

  1990cites this paper
• Pharmacology of cyclosporine. VI. Cellular activation: regulation of intracellular events by cyclosporine.

  1989cites this paper